CLOPIDOGREL VERSUS ASPIRIN IN PATIENTS AT RISK OF ISCHEMIC EVENTS

氯吡格雷与阿司匹林治疗有缺血事件风险的患者

• 批准号: 6245978
• 负责人: GEORGE W VETROVIC
• 金额: $ 2.76万
• 依托单位: VIRGINIA COMMONWEALTH UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-01-20 至 1997-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6245978
• 关键词: aspirin; atherosclerosis; cardiovascular disorder chemotherapy; chemoprevention; clinical research; drug screening /evaluation; health services research tag; human subject; human therapy evaluation; ischemia; myocardial infarction; outcomes research; peripheral blood vessel disorder; platelet aggregation inhibitors; stroke

To assess efficacy, safety, tolerability of clopidogrel and aspirin in reducing incident of composite outcome of ischemic stroke, myocardial infarction or vascular death among patients who have survived ischemic stroke, MI, or symptomatic atherosclerotic peripheral arterial disease.

评估氯吡格雷和阿司匹林在以下患者中的疗效、安全性和耐受性： 减少缺血性卒中、心肌梗死、 在缺血性心脏病患者中存活的 中风、MI或症状性动脉粥样硬化性外周动脉疾病。